105 related articles for article (PubMed ID: 18685897)
1. Metastatic dormancy imposed by the primary tumor: does it exist in humans?
Peeters CF; de Waal RM; Wobbes T; Ruers TJ
Ann Surg Oncol; 2008 Nov; 15(11):3308-15. PubMed ID: 18685897
[TBL] [Abstract][Full Text] [Related]
2. Modeling growth kinetics and statistical distribution of oligometastases.
Withers HR; Lee SP
Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
[TBL] [Abstract][Full Text] [Related]
3. New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
Goss P; Allan AL; Rodenhiser DI; Foster PJ; Chambers AF
APMIS; 2008; 116(7-8):552-68. PubMed ID: 18834402
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell dormancy: implications for the biology and treatment of breast cancer.
Fehm T; Mueller V; Marches R; Klein G; Gueckel B; Neubauer H; Solomayer E; Becker S
APMIS; 2008; 116(7-8):742-53. PubMed ID: 18834416
[TBL] [Abstract][Full Text] [Related]
5. Tumor-vascular interactions and tumor dormancy.
Naumov GN; Folkman J; Straume O; Akslen LA
APMIS; 2008; 116(7-8):569-85. PubMed ID: 18834403
[TBL] [Abstract][Full Text] [Related]
6. Cancer metastasis: a search for therapeutic inhibition.
Dimitroff CJ; Sharma A; Bernacki RJ
Cancer Invest; 1998; 16(4):279-90. PubMed ID: 9589037
[TBL] [Abstract][Full Text] [Related]
7. Tumor dormancy of primary and secondary cancers.
Udagawa T
APMIS; 2008; 116(7-8):615-28. PubMed ID: 18834406
[TBL] [Abstract][Full Text] [Related]
8. Tumor dormancy and metastasis.
Hedley BD; Chambers AF
Adv Cancer Res; 2009; 102():67-101. PubMed ID: 19595307
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
Uesaka D; Demura Y; Ishizaki T; Ameshima S; Miyamori I; Sasaki M; Fujibayashi Y; Okazawa H
J Nucl Med; 2008 Oct; 49(10):1606-12. PubMed ID: 18794269
[TBL] [Abstract][Full Text] [Related]
11. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.
Pierga JY; Bidard FC; Mathiot C; Brain E; Delaloge S; Giachetti S; de Cremoux P; Salmon R; Vincent-Salomon A; Marty M
Clin Cancer Res; 2008 Nov; 14(21):7004-10. PubMed ID: 18980996
[TBL] [Abstract][Full Text] [Related]
13. [The usefulness of whole body FDG-PET/CT in patients with brain metastasis].
Nakagawa K; Aoyagi M; Inaji M; Maehara T; Toriyama H; Kawano Y; Tamaki M; Nariai T; Ohno K
No Shinkei Geka; 2009 Feb; 37(2):159-66. PubMed ID: 19227157
[TBL] [Abstract][Full Text] [Related]
14. Solitary cancer cells as a possible source of tumour dormancy?
Naumov GN; MacDonald IC; Chambers AF; Groom AC
Semin Cancer Biol; 2001 Aug; 11(4):271-6. PubMed ID: 11513562
[TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
[TBL] [Abstract][Full Text] [Related]
16. Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy.
Beecken WD; Engl T; Jonas D; Blaheta RA
Int J Mol Med; 2009 Feb; 23(2):261-6. PubMed ID: 19148551
[TBL] [Abstract][Full Text] [Related]
17. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures.
Demicheli R; Retsky MW; Hrushesky WJ; Baum M
Nat Clin Pract Oncol; 2007 Dec; 4(12):699-710. PubMed ID: 18037874
[TBL] [Abstract][Full Text] [Related]
18. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
19. Cellular interactions in the vascular niche: implications in the regulation of tumor dormancy.
Favaro E; Amadori A; Indraccolo S
APMIS; 2008; 116(7-8):648-59. PubMed ID: 18834409
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
